Earlier this year, the Court of Justice of the European Union, in Oliver Brüstle v Greenpeace e.V, cast a decision that has wide-ranging implications for research on human embryonic stem cells and subsequent commercial development. The court revoked a patent previously granted to German stem cell researcher Oliver Brüstle for a method to generate nerve cells from human embryonic stem cells. The...